ArticleSurgical neurology international2025
Outcomes of endoscopic third ventriculostomy in comparison to ventriculoperitoneal shunt in obstructive hydrocephalus - A randomized controlled trial.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of choroid plexus cauterization in augmenting the success rate of endoscopic third ventriculostomy in Chiari II-associated hydrocephalus.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026Article
- Cerebrospinal Fluid Shunts: An Updated Radiologic Review of Devices, Malfunctions, and Complications.Korean journal of radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Most of the present literature comparing endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) are retrospective analysis or prospective case studies which carry a low level of evidence. Our study is a randomized controlled trial (RCT) which provides higher level of evidence required to answer the debate as to which is a better modality of treatment in obstructive hydrocephalus comparing the efficacy, clinical profile, and failure of these two interventions. Methods: This experimental RCT was conducted at in the department of neurosurgery. We enrolled patients with symptomatic obstructive hydrocephalus based on inclusion and exclusion criteria. Patients were randomized into ETV and VPS groups from December 2022 to January 2024, with a minimum follow-up of 6 months until June 2024. Outcomes were compared preoperatively and postoperatively using the Statistical Package for the Social Sciences 22.0 for statistical analysis. Results: Forty-four patients participated, with 22 in each group. Hydrocephalus due to tumors was observed in 70.4% of patients, 43.2% of whom had posterior fossa tumors. Clinical symptom resolution occurred in 90.9% of the ETV group and 100% of the VPS group ( Conclusion: There was a lower failure rate in the VPS group but VPS had more complications compared to ETV. As an RCT, this study provides a higher level of evidence and gives relevance to these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.